A newly published expert review has confirmed trial data — from a late-stage study dubbed TRANSCEND — showing that treatment…
Marisa Horak MS
Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak MS
A Race Against Blindness, a nonprofit dedicated to funding research into Bardet-Biedl syndrome (BBS) and other inherited conditions…
People with Bardet-Biedl syndrome (BBS) caused by a mutation called p.(Met390Arg) in both copies of the BBS1 gene may…
Genetic susceptibility toward obesity has little impact on whether lifestyle interventions aimed at weight loss are successful in children who…
People who are genetically predisposed toward obesity or having high levels of so-called “bad” cholesterol — low-density lipoprotein (LDL)…
People whose genetics predispose them towards obesity are more likely to develop chronic kidney disease (CKD), a new study…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops…
A tiny RNA molecule, or microRNA, called miR-128-1 helps to regulate metabolism and could be a treatment target in…
The heritability of obesity-related traits is similar in Japanese and European populations but the way these traits are interrelated…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…